Faculty: Baris Turkbey, Peter Choyke & Rajan Gupta

Moderators: Rafael Sanchez-Salas & Tom Polascik

Baris Turkbey

Dr. Turkbey obtained his medical degree from Hacettepe University in Ankara, Turkey in 2003. He completed his residency in Diagnostic and Interventional Radiology at Hacettepe University. He joined Molecular Imaging Branch, National Cancer Institute, NIH in 2007. His main research interests focus on prostate cancer imaging (multiparametric MRI, PET CT), prostate biopsy techniques, focal therapy for prostate cancer and image processing (segmentation, decision support systems). Dr. Turkbey directs the Artificial Intelligence Resource (AIR), which makes AI tools available to CCR investigators with the goal of developing better screening and detection methods or predictive markers for patients.

Peter Choyke

Dr. Peter Choyke is a Senior Investigator and Chief of the Molecular Imaging Branch of the National Cancer Institute. He received his medical degree from Jefferson Medical College and trained in Diagnostic Radiology at Yale and completed a fellowship at Penn. He has focused on the translation of imaging from the laboratory to the clinic for several different cancer types, with an emphasis on cancers of genitourinary tract. In addition, he has co-developed image guided therapies based on MRI, radionuclides and optical fluorophores. For instance, he has co-developed an optically activated form of cancer therapy known as photoimmunotherapy which is currently in Phase 3 testing.

Rajan Gupta

Rajan T. Gupta, MD, is the Chief of the Division of Abdominal Imaging at Duke University Medical Center and holds the rank of Associate Professor of Radiology with tenure. He has also been awarded a dual appointment in the Duke Department of Surgery based on his work with colleagues in Duke Urology and holds the secondary titles of Associate Professor of Surgery and faculty in the Duke Cancer Institute. Dr. Gupta has authored/coauthored approximately 100 peer- reviewed publications on topics ranging from imaging with hepatobiliary specific MR contrast agents to multiparametric prostate MRI. He has given 100+ invited lectures across the United States and internationally and has also been a co-investigator on two NIH R01 grants with Duke Biomedical Engineering. Dr. Gupta has also been named the Director of Imaging for the newly created Duke Cancer Institute Center for Prostate & Urologic Cancers. This position oversees and supports emerging imaging modalities and techniques that assist in furthering research and clinical care. Dr. Gupta will lead the team in fostering collaborations across nuclear and radiologic imaging at Duke, while partnering with industry investigators to further develop image-guided therapeutics. He will also continue to develop rising stars in the imaging field through mentorship.

Rafael Sanchez-Salas

Rafael Sanchez Salas in a Franco-Venezuelan Urologic Surgeon born in Mérida-Venezuela. He received his medical degree from the Universidad de los Andes in Mérida-Venezuela in 1998 with a Magna laude diploma and the first place of his class rank. Subsequently, he obtained degrees in General surgery and Urology from the Universidad Central de Venezuela, both at the University Hospital of Caracas. He followed with a Fellowship research on Urologic oncology at Memorial Sloan Kettering Cancer Center and clinical fellowships of Endourology and Advanced Laparoscopic Surgery and Urological Robotic Surgery at the Santa María Clinic in Santiago, Chile and at the Institut Mutualiste Montsouris in Paris,France, respectively. At the end of his training period in Paris, he joined the Department of Urology team at the Institut Mutualiste Montsouris, where he is currently an Attending Surgeon. He holds French State Diplomas in Clinical Oncology and Urological Oncology. He sits on several international Urological Boards and serves as reviewer for major Urological journals. Dr. Sanchez-Salas career is characterized by sustained work with academic orientation.